Ares Upsizes Plenitude Stake to 26% with €1B Capital Injection
ARES sits 22% above its 52-week low of $95.8.
Summary
Ares is committing over €1 billion to Plenitude, increasing its stake from 20% to 26.24% at a €10.75 billion pre-money valuation. The deal also gives Ares joint control and three board seats, including the chairman role. This deepens Ares' exposure to the energy transition business it first backed in 2025. The capital injection strengthens Plenitude's balance sheet and signals conviction in its growth plans. Watch for further details on funding sources and any impact on Ares' fee-related earnings.
At the time of this announcement, ARES was trading at $116.45 on NYSE in the Finance sector, with a market capitalization of approximately $26B. The 52-week trading range was $95.80 to $181.19. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.